Vutrisiran Treatment and Cardiac and Amyloid Changes on MRI

Дата публикации: 12-08-2026 00:00:00

This cohort study investigates if vutrisiran treatment was associated with longitudinal changes in cardiac structure, function, and amyloid burden in patients with transthyretin amyloid cardiomyopathy who were assessed with cardiovascular magnetic resonance imaging (MRI).

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy	0	7.14	19-08-2026
2	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
3	Cardiac Risk After Heart-Sparing Breast Radiotherapy	0	5	02-07-2026
4	Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome	0	6.92	01-10-2023
5	White Matter Hyperintensities in Alzheimer Disease	0	6.14	01-12-2023
6	Spectrum of Aldosteronism and Cardiovascular Outcomes	0	6.27	01-04-2026
7	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026
8	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
9	Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation	0	15.41	29-07-2026
10	Cardiac MRI reveals distinct mechanisms in heart failure with preserved ejection fraction	0	5.18	22-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.2. Источник: jamanetwork.com.